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Caged Fluorescent Haptens Reveal the Generation
of Cryptic Epitopes in Allergic Contact Dermatitis
Carl Simonsson1,4, Sofia I. Andersson1,4, Anna-Lena Stenfeldt1, Jo¨rgen Bergstro¨m2, Brigitte Bauer3,
Charlotte A. Jonsson1, Marica B. Ericson3 and Kerstin S. Broo1
Allergic contact dermatitis (ACD) is the most prevalent form of human immunotoxicity. It is caused by skin
exposure to haptens, i.e., protein-reactive, low-molecular-weight chemical compounds, which form hapten–-
protein complexes (HPCs) in the skin, triggering the immune system. These immunogenic HPCs are elusive.
In this study a series of thiol-reactive caged fluorescent haptens, i.e., bromobimanes, were deployed in
combination with two-photon fluorescence microscopy, immunohistochemistry, and proteomics to identify
possible hapten targets in proteins in human skin. Key targets found were the basal keratinocytes and the
keratins K5 and K14. Particularly, cysteine 54 of K5 was found to be haptenated by the bromobimanes. In
addition, elevated levels of anti-keratin antibodies were found in the sera of mice exposed to bromobimanes
in vivo. The results indicate a general mechanism in which thiol-reactive haptens generate cryptic epitopes
normally concealed from the immune system. In addition, keratinocytes and keratin seem to have an important
role in the mechanism behind ACD, which is a subject for further investigations.
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INTRODUCTION
Topical exposure to low-molecular-weight chemical com-
pounds can cause allergic contact dermatitis (ACD) (Karlberg
et al., 2008). Affecting 15–20% of the population in the
Western world, ACD constitutes the most prevalent form
of human immunotoxicity (Thyssen et al., 2007). Once an
individual is sensitized, there is no cure, but the offending
compound and any crossreacting compounds will have to
be avoided. The growing list of compounds that can cause
ACD (i.e., haptens) today comprises 44,350 substances
(De Groot, 2008).
ACD is a T-cell-mediated delayed-type hypersensitivity
reaction. The basic mechanism behind ACD was described in
a seminal paper published as early as 1935 (Landsteiner and
Jacobs, 1935) in which the key step in sensitization was
proposed to be the formation of an immunogenic hapten–-
protein complex (HPC), e.g., covalent bond formation
between electrophilic haptens and carrier proteins. Since
then, it has been shown that antigen-presenting cells in the
skin, i.e., Langerhans cells and dermal dendritic cells, migrate
to the regional lymph nodes and present epitopes of the HPCs
on major histocompatibility complex molecules to naive
T cells. T cells with a matching T-cell receptor become
activated, proliferate, and differentiate into a specific T-cell
progeny that is released into the circulatory system. These
‘‘patrolling’’ antigen-specific T cells are responsible for the
clinical outcome in sensitized individuals (Rustemeyer et al.,
2001). Although ACD is one of the most studied immuno-
logically mediated toxicities, several details about its
mechanisms are still lacking. For example, major histocom-
patibility complex-restricted haptenated epitopes have yet to
be identified. Furthermore, it is not known where in the skin
the haptenation reaction occurs, if the primary cellular targets
are keratinocytes or antigen-presenting cells, or if intra- or
extra-cellular proteins are targeted. Also, the targeted protein
sequences remain elusive. Better understanding of these
processes might be helpful in the development of predictive
in vitro tests of potentially allergenic compounds in consumer
products that can replace the murine local lymph node assay
(LLNA), the OECD (Organization for Economic Co-operation
and Development) standard model for predictive testing
(Kimber et al., 2002). This is an urgent need, because of the
animal testing ban of cosmetic products (2009) and the
coming up marketing ban of animal-tested cosmetic products
(2013) in the European Union (EU, 2003).
To decode sensitization, i.e., identify target proteins and
reveal the exact position of haptenation, haptenated proteins
need to be singled out with molecular precision against the
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entire backdrop of the proteome. To meet this challenge, we
have deployed caged thiol-reactive haptens (bromobimanes,
Figure 1) that are nonfluorescent before an bimolecular
nucleophilic subtitution displacement of the bromine atom
(Kosower et al., 1979). Excised human skin has been exposed to
the bromobimanes in vitro. The locations of the fluorescent
products have been visualized using two-photon fluorescence
microscopy (TPM), and the protein targets analyzed using mass
spectrometry (experimental flowchart, Supplementary Figure S1
online). In contrast to typical caged probes (Ellis-Davies, 2007),
uncaging of bromobimanes is not in the hands of the researcher,
but a consequence of biology occurring preferably with thiols at
physiological pH (Kosower et al., 1979). Cysteines are thus
potential endogenous nucleophiles in the formation of uncaged
HPCs. Preferential reactivity toward thiols is advantageous as
many clinical haptens are thiol reactive (Gerberick et al., 2004).
Also, the question of how to relate haptenation reactions by
monodentate haptens (one reactive group) to those of bidentate
haptens (two reactive groups) is addressed. Bromobimanes with
one (monobromobimane (mBBr)) or two (dibromobimane
(dBBr)) reactive groups were thus deployed with the goal of
identifying hapten targets in the skin and increasing knowledge
regarding the development of ACD.
RESULTS
Bromobimanes as haptens
Using the murine LLNA, the bromobimanes were found to be
strong sensitizers with EC3 values (the concentration giving a
stimulation index of three in the LLNA) in the range of 4mM
(Figure 1). They are thus ideal chemical probes for addressing
the molecular pathway of ACD. The nonreactive, perma-
nently fluorescent analog methylbimane was nonsensitizing,
in accordance with the postulated need for covalent
hapten–protein binding to form the immunogenic HPCs
(Landsteiner and Jacobs, 1935).
The EC3 values for mBBr and dBBr were found to be
virtually identical (Figure 1), although the numbers of reactive
groups differ, i.e., the monodentate mBBr reacts with one
thiol group, whereas the bidentate dBBr links two sulfhydryl
groups. As their molecular weight and theoretical average
logP values are comparable (dBBr: 1.87±0.86, mBBr:
1.45±0.85) (http://www.vcclab.org, accessed 2009) (Tetko
et al., 2005), the penetration profiles of the compounds in skin
are expected to be similar. In vitro experiments verified that
both mBBr and dBBr react swiftly with glutathione, despite the
difference in the number of reactive groups (Supplementary
Figures S2–S5 online). In skin, there are numerous disulfide
linkages between the cysteines in proteins to ensure the
mechanical integrity. dBBr was not able to react with oxidized
sulfhydryls (disulfides) or to reduce disulfides in vitro (data not
shown), indicating that reduced sulfhydryls are bimane targets.
The time to complete reaction with sulfhydryls was similar for
mBBr and dBBr, as was the slow rate of hydrolysis after
24hours of incubation at pH 7 (data not shown).
Basal cells are hapten targets
The localization of fluorescent HPCs in skin was visualized
by TPM to enable detection without compromising the
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Figure 1. Local lymph node assay (LLNA) dose-response curves and chemical structures for monobromobimane (mBBr), dibromobimane (dBBr), and
methylbimane. All compounds were tested in DMSO. Cell proliferation in the lymph nodes following topical application of test chemicals was determined by
measuring the concentration of 3HTdR by b-scintillation counting. The results are given as mean disintegrations per minute (d.p.m.). mBBr and dBBr were strong
sensitizers, whereas methylbimane was a nonsensitizer at the concentrations tested. NA, no value available.
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integrity of the tissue. Full-thickness human skin was
incubated with bimanes (5–20mM) for 20 hours in a skin
permeation system and consecutively imaged by TPM. Also,
bromobimane-exposed skin was cryosectioned and imaged
with laser scanning confocal microscopy to confirm the
localization seen with TPM.
TPM showed an intense labeling of the stratum corneum
(Figure 2), as earlier observed for other reactive compounds
(Samuelsson et al., 2009). This is in accordance with the
biological role of stratum corneum as a protective physical
barrier with a significant amount of degraded proteins and
free, and thus unhindered, amino acids available for reaction
(Sylvestre et al., 2010). Intriguingly, covalent binding of the
bromobimanes to proteins in the suprabasal cell layers was
less frequent. Instead, the haptens penetrated down to the
basal layer, where reaction readily occurred. The reactivity
pattern of the bromobimanes can be explained by the
availability of protein targets, e.g., free thiols, in combination
with changes in the cell membrane integrity, e.g., formation
of cornified envelope across the epidermis (Figure 3; Sun and
Green, 1978; Candi et al., 2005). Also, because of the lipid
composition of the basal cell membrane (Hachisuka et al.,
1990), it has a relatively high fluidity, facilitating cell
penetration and reaction with intracellular free thiols,
forming HPCs. This distribution correspond to that observed
in skin biopsies obtained from human volunteers exposed to
1-chloro-2,4-dinitrobenzene, a very potent thiol-reactive
hapten (EC3¼ 0.05% (w/v; Gawkrodger et al., 1989; Kimber
et al., 2002)).
The reaction pattern of the bromobimanes also revealed
labeling of clusters of cells within the basal layer (Figure 2).
This phenomenon was reproducible throughout several
independent experiments (n¼ 13) using tissues from different
donors (n¼ 6). The epidermis consists of roughly 95%
keratinocytes, whereas immature antigen-presenting Langer-
hans cells make up 1–3% of the epidermal cells (Bauer et al.,
2001). The scarcity of the labeled cells suggested that
Langerhans cells were targets. However, this was ruled out
by laser scanning confocal microscopy colocalization studies
of bromobimane-exposed tissue with CD1a antibodies
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Figure 3. Changes in skin composition and structure during keratinocyte differentiation, and the availability of protein targets, i.e., free thiols, in the
epidermis. While the keratin content increases toward the skin surface, the cysteines of the keratins in stratum corneum (SC) are highly crosslinked by
intermolecular disulfide bonds. In addition, the cornified envelope, formed during the terminal differentiation of the keratinocytes, results in more rigid, thicker,
and less permeable cell membranes. In SC, degraded proteins and free amino acids could be potential hapten targets. Free thiols are abundant inside the cells in
the layers of stratum spinosum and basale. However, in the suprabasal layers, K1 and K10 are extensively bundled and crosslinked, hiding the cysteines. The
relatively high membrane fluidity of the basal cells may facilitate cell penetration and reaction with intracellular cysteines of K5 and K14.
Figure 2. Two-photon fluorescence microscopy (TPM) images of human skin
incubated with bromobimanes. The skin samples were exposed to (a–c)
monobromobimane (mBBr), (d–f) dibromobimane (dBBr), or (g–i)
methylbimane, using an in vitro skin penetration system for 20 hours. (Left
panel) Three-dimensional (3D) representations and optical cross-sections.
(Right panel) The xy-image planes of epidermis after incubation with mBBr
(c, z¼52 mm), dBBr (f, z¼ 62mm), and methylbimane (i, z¼50 mm). Scale
bar¼ 50 mm for all images. Arrows indicate bimane-labeled cells present in
the basal layer of the epidermis.
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expressed by Langerhans cells (Figure 4). Instead, colocaliza-
tion with keratinocyte-specific antibodies showed that the
labeled cells were keratinocytes in the basal layer, as shown
in the figure.
The basal layer is the only mitotic cell layer in the
epidermis and it is home to the stem cell (progenitor)
keratinocytes that afford continuous renewal of the squamous
epidermis. The progenitor cells make up B10% of the basal
cells, and have been shown to form clusters, the so-called
stem cell niches, in in vivo clonal-labeling experiments
(Clayton et al., 2007). The clusters correspond to the
localization pattern of the uncaged HPCs in our study. This
raises the interesting notion that the targeted keratinocytes
might be the stem cells.
Basal cell keratins are targeted in tissue
To pinpoint the hapten–protein targets, labeled proteins
present in the skin pieces were visualized by their bimane
fluorescence following SDS-PAGE separation (Figure 5a).
Incubation with mBBr and dBBr resulted in prominent
fluorescent protein bands. The haptenation did not simply
reflect the amount of a protein, as can be seen by comparing
the Coomassie-stained gel (Supplementary Figure S6 online)
with detection through bimane fluorescence. Thus, some
proteins seem especially prone to reaction with thiol-reactive
haptens.
The molecular weights of the most intense fluorescent
band for mBBr (Figure 5a) suggested that a protein with a
molecular weight of B60 kDa could be a target. In
keratinocytes, obligatory heterodimeric keratin pairs (type I
and type II) make up the cytoskeletal keratin intermediate
filament network. Epithelial tissues express different pairs of
keratins depending on the cell type and the stage of
differentiation (Eichner et al., 1986; Steinert, 1993; Fuchs
and Cleveland, 1998). The progenitor keratinocytes in the
basal layer express the keratin 5/keratin 14 (K5/K14), which
constitutes 25–35% of the total protein content of the cells.
This pair is replaced by the K1/K10 pair in the suprabasal
layers (Sun and Green, 1978), where it accounts for as much
as 80–85% of the total cellular content of a fully differentiated
keratinocyte. The cysteines of K1 and K10 are hidden through
extensive bundling and crosslinking of K1/K10 in the
suprabasal layers (Moll et al., 2008), which limits their
potential to react with the bromobimanes. As TPM revealed
bimane localization to the basal layer (Figure 2), and the
molecular weight of K5 (58 kDa) corresponds to the most
fluorescently intense protein band in the SDS-PAGE (Figure
5a), K5 is a likely target for haptenation. Western blot
experiments performed with polyclonal antibodies directed
against K5 showed that the fluorescent band colocalized with
K5 (Figure 5b). In contrast, tissue exposed to dBBr revealed a
prominent fluorescent band around B100 kDa (Figure 5a),
raising the issue whether this band could correspond to a
crosslinking of two K14 monomers (100 kDa), two K5
monomers (116 kDa), and/or a K5/K14 heterodimer
(108 kDa) by the bidentate hapten. This notion was con-
firmed through a western blot with polyclonal antibodies
directed against K5 or K14, respectively (Figure 5b). As K5
and K14 are present in a 1:1 stoichiometry, the localization
pattern of mBBr and dBBr should appear very similar at the
resolution of TPM and confocal microscopy, in accordance
with our results. In addition, this agrees with a study on
cultured human keratinocytes exposed to bidentate deriva-
tives of mustard gas, demonstrating multimerization of K5/K5,
K14/K14, and K5/K14 (Dillman et al., 2003). This suggests
that K5 and K14 are important targets for bidentate haptens
also (here dBBr), providing a molecular explanation for the
observed immunological phenomenon; matching EC3 values
(Figure 1) and the location of reaction in tissue (Figure 2)
using the bromobimanes. In tissue experiments, the anti-K5
and anti-K14 antibodies label the basal keratinocytes and the
stratum corneum but not the suprabasal layers in the xy-
sections of skin (data not shown). This result is likely because
Figure 4. Confocal and immunohistochemistry images of skin exposed to
bromobimanes. (a) Skin incubated with monobromobimane (mBBr) and
(b) dibromobimane (dBBr). Immunofluorescence using (c) keratin 5 (K5),
(d) keratin 14 (K14), and (e) CD1a antibodies of skin exposed to mBBr. Panels
from left to right: mBBr fluorescence images, immunofluorescence images,
merged fluorescence images (cyan channel¼mBBr and magenta
channel¼ immunofluorescence), and intensity correlation plots. The Manders
overlap coefficients for mBBr and immunofluorescence were 0.92, 0.80, and
0.40 for K5, K14, and CD1a, respectively. Arrows highlight clusters of cells
with elevated fluorescence. Scale bars¼ 30 mm for all images.
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of the partial degradation of proteins in the outermost
layers of the skin (Sylvestre et al., 2010), leading to exposure
of epitopes that are otherwise hidden through bundling
and crosslinking of K1/K10 in the suprabasal layers. Taken
together, these results imply that K5 and K14 are important
protein targets when human skin is exposed for thiol-
reactive haptens.
Haptens target cysteine 54 (C54) of K5
In order to find the exact site of haptenation on keratin, the
two most prominent fluorescent protein bands on the SDS gel
(Figure 5a) were excised and subjected to tryptic digestion
with subsequent liquid chromatography–tandem mass spec-
trometry analysis. In accordance with the western blot results,
positive identification of K5 in the band of 58 kDa, and
K5 plus K14 in the band of B100 kDa, were afforded in
the MASCOT (Matrix Science, London, UK) search of all the
tandem spectra (Supplementary Figure S7 online). In the
following manual analysis of the mass spectrometry spectra,
no dBBr-modified peptide fragment could be observed in the
band of B100 kDa. This is probably because of the fact that
crosslinking agents give rise to fragments that are too large for
detection in the mass spectrometer. In the 58 kDa protein
band, the tryptic fragment of K5 containing C54 (amino acids
V48 to R62; Figure 6) could not be found. However, a
fragment corresponding to the weight of the C54 fragment
plus the weight of one bound mBBr could be detected as the
M2þ ion with a m/z of 772.37. The tandem mass spectro-
metry fragmentation pattern was in accordance with a C54-
bimane-derivatized tryptic fragment (V48 to R62; Figure 5).
We thus found evidence that the thiol-reactive hapten mBBr
modifies C54 of K5 in intact, full-thickness human skin. To
our knowledge, exact hapten reaction sites in skin are
previously unreported.
Haptens provoke production of K14 antibodies in vivo
To this point, the hapten targets were studied in excised
human tissue ex vivo. To investigate the clinical relevance of
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Figure 5. SDS-PAGE and western blot of epidermis samples. (a) SDS-PAGE of epidermis samples exposed to bromobimanes visualized by fluorescence
(excitation: 480 nm, emission: 530 nm). The arrows point at the protein bands at 58 kDa and B100 kDa that were excised for liquid chromatography-mass
spectrometry (LC-MS) analysis. (b) Western blot of epidermis samples. Left panel: anti-keratin 5 (K5) primary antibody. Right panel: anti-keratin 14 (K14)
primary antibody. Blank refers to skin sample subjected to buffer (PBS) only. The K5-positive control carries a glutathione S-transferase (GST) tag, explaining
the significantly higher molecular weight. All numbers indicate MR 103. dBBr, dibromobimane; mBBr, monobromobimane.
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Figure 6. Tandem mass spectrometry (MS/MS) fragmentation spectra. Tryptic fragment V48–R62 of keratin 5 (K5), modified by monobromobimane
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the finding that keratins are the hapten targets for the thiol-
reactive bromobimanes, the hypothesis had to be tested in an
in vivo setting. A modified LLNA experiment was performed
where serum samples from mice subjected to mBBr or dBBr
were collected. To investigate if the sera contained anti-
keratin antibodies, the serum samples were analyzed by
an anti-K14 ELISA. Indeed, elevated levels of anti-keratin
antibodies were found in the sera of mice exposed to mBBr
and dBBr compared with irritant control (Supplemen-
tary Figure S9 online). This suggests that exposure to the
bromobimanes in vivo generates cryptic epitopes normally
concealed from the immune system, which supports our
ex vivo findings.
DISCUSSION
Using thiol-reactive caged fluorophores, i.e., bromobimanes,
as model haptens, this study demonstrates that keratins K5
and K14 in keratinocytes may have an important role in the
mechanism of ACD. As keratinocytes make up B95% of
the epidermis, their importance in ACD is not surprising.
Furthermore, the key role of keratins in sensitization and
elicitation can be considered to be a matter of yield, as
keratins make up X80% of the total cellular protein in fully
differentiated keratinocytes, and up to 35% of the basal
keratinocytes.
The identified hapten target, i.e., amino acid C54 of K5, is
located in the head region of the protein, a region that makes
crucial contacts with desmoplakin in the desmosomes
(Kouklis et al., 1994). The basal cells in epithelia are welded
tightly together by bundling keratins together into strong
keratin intermediate filaments. This ensures a high effective
local concentration of the peptide stretch containing C54,
and thus strong anchoring to desmoplakin, strengthening
the epithelial integrity. This position reduced C54 in a high
effective concentration just inside the cell membranes,
constituting an ideal target for incoming electrophilic
haptens. Thus, as our results demonstrate that C54 is a key
target of thiol-reactive haptens, this implies that the formed
HPC may cause a malfunction of the desmoplakin anchoring.
This could result in destruction of the desmosomes, and the
release of cryptic epitopes from dying keratinocytes. These
cryptic epitopes could then be taken up by the antigen-
presenting cells of the skin and be presented to naive T cells
in the lymph nodes, sensitizing the exposed individual.
Furthermore, as anti-K14 antibodies were detected in the
serum of hapten-exposed mice, this indicates that hapten-
specific T cells provide the necessary help to B cells in
recognizing K14 to become activated and produce anti-K14
antibodies.
Many clinically relevant haptens are thiol reactive
(Gerberick et al., 2004; Natsch and Gfeller, 2008). Thus,
the bromobimanes, which are selectively reacting with thiols,
serve as good model compounds for clinically relevant
haptens. It should be noted that haptens with different
chemical reactivity might lead to binding to other protein
targets (Meschkat et al., 2001; Gerberick et al., 2007;
Karlsson et al., 2009). Indeed, other research groups have
described other hapten targets, e.g., using human serum
albumin and K14 as model proteins in vitro (Thierse et al.,
2004; Heiss et al., 2005; Aleksic et al., 2008; Dietz et al.,
2010; Jenkinson et al., 2010). However, this study is, to the
best of our knowledge, the only report on the identification
of a haptenation site in human skin tissue, obtained with
the complete set of potential skin protein targets available
for reaction.
A limitation of the study is the lack of viable cells in the
experiments performed on excised skin tissue ex vivo.
Nevertheless, serum samples from mice topically exposed
to the haptens confirm the formation of recurrent cryptic
epitopes in living organisms. This supports our ex vivo
findings, and further work on cell cultures is in progress.
Emerging from this work is a theory where recurring
neoepitopes are formed upon hapten exposure. The gener-
ated knowledge that keratinocytes might take an active role
in the development of ACD could be helpful in the
development of alternative methods replacing animal models
for allergy testing in the future. Based on these findings, the
generality of the proposed theory is now subject for further
investigations.
MATERIALS AND METHODS
Chemicals
Both dBBr and methylbimane were obtained from Sigma-Aldrich
(St Louis, MO) and mBBr from Merck (Darmstadt, Germany).
All other chemicals were purchased from Sigma-Aldrich unless
otherwise stated.
LLNA
Sensitization potential of the compounds was tested in DMSO
using the LLNA. The experiments were approved by the local ethics
committee and performed as described elsewhere (Samuelsson
et al., 2009).
Two-photon microscopy
Full-thickness human skin obtained from breast reduction surgery,
stored at 70 1C and used within 3 months from surgery, was
mounted in vertical (Franz-type) skin penetration systems (Labora-
tory Glass Apparatus, Berkely, CA) and exposed to vehicles prepared
from stock solutions of bimanes in ACN, by dilution with phosphate-
buffered saline (PBS), giving a final concentration of 5–20mM in PBS/
ACN (9:1). The vehicle (0.5ml) was added to the donor compart-
ment and the acceptor compartment was filled with PBS. The skin
was incubated for 20 hours at 32 1C. The bimane-exposed skin
samples were rinsed with PBS and mounted in imaging chambers.
TPM was performed (see Supplementary Materials and Methods
online for details).
Immunohistochemistry and confocal microscopy
Skin exposed to bimane solutions were subject to vertical
cryosectioning. The samples were incubated in normal nonimmune
goat serum (Invitrogen, Carlsbad, CA) before incubation with
primary antibodies: CD1a mouse anti-human monoclonal antibody
(Santa Cruz Biosciences, Santa Cruz, CA) or K5 and K14 guinea pig
anti-human polyclonal antibodies (Lifespan Biosciences, Seattle,
WA); and secondary antibodies: tetramethyl rhodamine isothiocya-
nate (TRITC)-labeled goat anti-mouse (Santa Cruz Biosciences) or
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Alexa Fluor 633-labeled goat anti-guinea pig antibodies (Invitrogen).
The sections were thereafter imaged using laser scanning confocal
microscopy (see Supplementary Materials and Methods online for
details).
SDS-PAGE
The skin pieces exposed to bimanes were tape stripped to remove
stratum corneum and immersed in warm water (60 1C) for
60 seconds followed by separation of epidermis and dermis. Proteins
were extracted by heating the samples in SDS/Tris-buffer, pH 8.5.
The concentration of proteins in each sample was determined by
BCA Protein Assay (Pierce, Rockford, IL).
The samples were diluted with XT Sample Buffer 4X (Bio-Rad,
Hercules, CA) and Milli-Q grade water (Millipore, Billerica, MA).
Dithiothreitol (1ml; 2 M) was added to each sample followed by
heating at 96 1C for 2minutes before application on 10% Bis-Tris
precast polyacrylamide gels (Invitrogen).
Electrophoresis was performed using 3-(N-morpholino)propane-
sulfonic acid running buffer. The gels were fixed, scanned for
fluorescence (excitation 400 nm, emission 530 nm) using a 2920 2D
MasterImager (Amersham Pharmacia Biotech, Uppsala, Sweden),
and stained with Bio-Safe Coomassie G-250 (Bio-Rad).
Western blot
Unfixed gels were blotted onto polyvinyldifluoride membranes (Bio-
Rad). The blots were blocked for 2 hours in buffer containing 50mM
Tris-HCl, 0.2M NaCl, and 3% nonfat dry milk (Bio-Rad), incubated
for 1 hour with primary K5 or K14 guinea pig anti-human poly-
clonal antibodies (1:5,000; Lifespan Biosciences), and incubated for
30minutes with a peroxidase-labeled rabbit anti-guinea pig IgG
(Hþ L) secondary antibody (Invitrogen; 1:2,000). The blots were
washed 3 10minutes with buffer consisting of 50mM Tris-HCl,
0.2 M NaCl, and 0.05% Tween-20 between each step and developed
with 3,30-diaminobenzidine.
In-gel trypsination, extraction of proteins, and nanoflow liquid
chromatography–tandem mass spectrometry
Selected protein bands were excised from the coomassie-stained
gel and analyzed with nanoflow liquid chromatography–tandem
mass spectrometry (see Supplementary Materials and Methods
online for details).
ELISA
Sera obtained from mice exposed to bimanes or SDS for three
consecutive days were collected and pooled for each group (N¼ 3)
and analyzed by an anti-K14 ELISA. An antibody directed toward the
immunoglobulin classes IgA, IgM, and IgG was used (see Supple-
mentary Materials and Methods online for details).
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